New therapeutic opportunity for the treatment of resistant malignant melanoma

by University de LiegeMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A team of researchers led by Dr. Pierre Clos

Updated on: April 10,2024

New therapeutic opportunity for the treatment of resistant malignant melanoma

by University de LiegeMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0A team of researchers led by Dr. Pierre Clos

Updated on:April 10,2024

Low-risk, long-term cancer survivors more likely to die of non-cancer causes, study shows

by Jessica M. Scully,Yale UniversityCredit: Unsplash/CC0 Public DomainAdvances in early detection and treatment have vastly improved the long-term survival of people diagnosed with cancer.This i

Updated on: February 23,2024

Low-risk, long-term cancer survivors more likely to die of non-cancer causes, study shows

by Jessica M. Scully,Yale UniversityCredit: Unsplash/CC0 Public DomainAdvances in early detection and treatment have vastly improved the long-term survival of people diagnosed with cancer.This i

Updated on:February 23,2024

Medical students study tampons as possible screening test for cancer

by Ileana Varela,Florida International UniversityMedical students Jessica Seigel, Leah Cohen and Lauren Dittman are hoping their study leads to a screening test for ovarian cancer. Credit: Flori

Updated on: May 13,2024

Medical students study tampons as possible screening test for cancer

by Ileana Varela,Florida International UniversityMedical students Jessica Seigel, Leah Cohen and Lauren Dittman are hoping their study leads to a screening test for ovarian cancer. Credit: Flori

Updated on:May 13,2024

Bioengineers combine lab-on-a-chip technology with AI to improve cancer immunotherapy

byIndiana UniversityTheplatform tracks T cell infiltration of tumor spheroids, which are 3D structures made of cancer cells. Credit: Feng GuoAn interdisciplinary team of researchers led by

Updated on: January 04,2024

Bioengineers combine lab-on-a-chip technology with AI to improve cancer immunotherapy

byIndiana UniversityTheplatform tracks T cell infiltration of tumor spheroids, which are 3D structures made of cancer cells. Credit: Feng GuoAn interdisciplinary team of researchers led by

Updated on:January 04,2024

Study shows many expensive cancer drugs have unclear patient benefit

byUniversity of GothenburgDiseases targeted in the included trials. Credit:Clinical Drug Investigation(2023). DOI: 10.1007/s40261-023-01285-4New cancer drugs are being launched rapid

Updated on: January 16,2024

Study shows many expensive cancer drugs have unclear patient benefit

byUniversity of GothenburgDiseases targeted in the included trials. Credit:Clinical Drug Investigation(2023). DOI: 10.1007/s40261-023-01285-4New cancer drugs are being launched rapid

Updated on:January 16,2024

Breast cancer mortality reflected differently in certain Georgia neighborhoods, study reveals

by Adam Pope,University of Alabama at BirminghamAssociations Between Area Depriviation Index (ADI) and Probability of Patient Mortality for Black and White Patients With Breast Cancer. Data are

Updated on: January 30,2024

Breast cancer mortality reflected differently in certain Georgia neighborhoods, study reveals

by Adam Pope,University of Alabama at BirminghamAssociations Between Area Depriviation Index (ADI) and Probability of Patient Mortality for Black and White Patients With Breast Cancer. Data are

Updated on:January 30,2024

HPV DNA identified in oral cavity of 6.2 percent of teen girls

(HealthDay)—Human papillomavirus (HPV) DNA is detected in the oral cavities of about 6.2 percent of sexually active female adolescents, according to a study published online Oct. 25 inJAMA Netwo

Updated on: May 05,2024

HPV DNA identified in oral cavity of 6.2 percent of teen girls

(HealthDay)—Human papillomavirus (HPV) DNA is detected in the oral cavities of about 6.2 percent of sexually active female adolescents, according to a study published online Oct. 25 inJAMA Netwo

Updated on:May 05,2024

Cancer in those under 50 is rising, globally. Why?

by Siobhan Glavey,The ConversationCredit: AI-generated imageWe know what we need to do to reduce our risk of getting cancer, right? Wear SPF, stop smoking, avoid processed foods, keep fit, lose

Updated on: January 02,2024

Cancer in those under 50 is rising, globally. Why?

by Siobhan Glavey,The ConversationCredit: AI-generated imageWe know what we need to do to reduce our risk of getting cancer, right? Wear SPF, stop smoking, avoid processed foods, keep fit, lose

Updated on:January 02,2024

Research uncovers how to target 'sleeping' breast cancer cells and prevent relapse

byInstitute of Cancer ResearchModel: Endocrine therapy-induced dormancy is characterized by a consistent epigenetic reprogramming involving a global increase in histone repressive marks. The dor

Updated on: March 28,2024

Research uncovers how to target 'sleeping' breast cancer cells and prevent relapse

byInstitute of Cancer ResearchModel: Endocrine therapy-induced dormancy is characterized by a consistent epigenetic reprogramming involving a global increase in histone repressive marks. The dor

Updated on:March 28,2024

A myeloma-targeting monoclonal antibody offers new hope for treating multiple myeloma

by Osaka UniversitySummary of the research. Credit: Naoki HosenMultiple myeloma (MM) is a largely incurable cancer of plasma cells with an extremely poor prognosis. However, investigators from Ja

Updated on: May 07,2024

A myeloma-targeting monoclonal antibody offers new hope for treating multiple myeloma

by Osaka UniversitySummary of the research. Credit: Naoki HosenMultiple myeloma (MM) is a largely incurable cancer of plasma cells with an extremely poor prognosis. However, investigators from Ja

Updated on:May 07,2024

New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment

by Bob Yirka , Medical XpressScheme of genome editing of PDL1 by eOA effectively improved virotherapy and adoptive T-cell therapy. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-02

Updated on: March 05,2024

New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment

by Bob Yirka , Medical XpressScheme of genome editing of PDL1 by eOA effectively improved virotherapy and adoptive T-cell therapy. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-02

Updated on:March 05,2024

Bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma: Poorer treatment outcomes

byVall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainTreatment with bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma associates wit

Updated on: December 28,2023

Bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma: Poorer treatment outcomes

byVall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainTreatment with bendamustine prior to CAR T-cell therapy in patients with refractory large B-cell lymphoma associates wit

Updated on:December 28,2023